logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. National Institute of Oncology

+3612248600
kiss.zsuzsanna@onkol.hu
Source: Site record.
http://www.onkol.hu

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The National Institute of Oncology (OOI – Országos Onkológiai Intézet) is Hungary’s leading specialized cancer center, located in Budapest. It is the country’s central institution for cancer prevention, diagnosis, treatment, and oncology research, and serves as a national referral hub for complex cancer cases. The institute provides comprehensive oncology services, including medical oncology, surgical oncology, radiotherapy, diagnostic imaging, nuclear medicine, and palliative care. It is especially known for advanced treatments such as precision radiotherapy, targeted therapies, and multidisciplinary tumor boards that design individualized treatment plans for patients. OOI also plays a major role in clinical research and cancer epidemiology, contributing to international oncology trials and developing national cancer control strategies. It is closely connected with academic institutions and medical universities, making it an important training center for oncologists and…

Business Status

Source: Google. OPEN

Business Category

Source: Google. Hospital

Business Subcategory

Source: Google. Hospital
Source: Trial-derived.
22Total Trials
Source: Trial-derived.
6Recruiting Trials
Source: Trial-derived.
9Active Trials
Source: Trial-derived.
8Completed Trials
Source: Trial-derived.
25Unique Conditions
Source: Trial-derived.
30Unique Sponsors

Conditions

Source: Trial-derived. Breast Neoplasms (2)Source: Trial-derived. Cervical Cancer (2)Source: Trial-derived. Ovarian Cancer (2)Source: Trial-derived. Ovarian Neoplasms (2)Source: Trial-derived. Squamous Cell Carcinoma of the Head and Neck (2)Source: Trial-derived. Triple Negative Breast Neoplasms (2)Source: Trial-derived. Castration-Resistant Prostatic Cancer (1)Source: Trial-derived. Colorectal Cancer (1)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (5)Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. European Network of Gynaecological Oncological Trial Groups (ENGOT) (2)Source: Trial-derived. Merck KGaA, Darmstadt, Germany (2)Source: Trial-derived. Pfizer (2)Source: Trial-derived. AB Science (1)Source: Trial-derived. Alliance Foundation Trials, LLC. (1)Source: Trial-derived. ARCAGY/ GINECO GROUP (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. PET-CT
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. MRI

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Radiographic tumour response assessment
Source: AI-inferred. Sentinel lymph node mapping and biopsy